Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine.

MLA

Lachaine, Jean, et al. “Canadian Economic Impact of Improved Workplace Productivity in Patients with Major Depressive Disorder Treated with Vortioxetine.” CNS Spectrums, vol. 25, no. 3, June 2020, pp. 372–79. EBSCOhost, https://doi.org/10.1017/S1092852919000853.

APA

Lachaine, J., Beauchemin, C., Bibeau, J., Patenaude, J., Chokka, P., Proulx, J., & Bougie, J. (2020). Canadian economic impact of improved workplace productivity in patients with major depressive disorder treated with vortioxetine. CNS Spectrums, 25(3), 372–379. https://doi.org/10.1017/S1092852919000853

Chicago

Lachaine, Jean, Catherine Beauchemin, Joëlle Bibeau, Julie Patenaude, Pratap Chokka, Jean Proulx, and Joanna Bougie. 2020. “Canadian Economic Impact of Improved Workplace Productivity in Patients with Major Depressive Disorder Treated with Vortioxetine.” CNS Spectrums 25 (3): 372–79. doi:10.1017/S1092852919000853.